1

August 20, 2012 CURRICULUM VITAE

Peter David Friedmann, MD, MPH, FASAM, FACP

Business Addresses: Division of General Internal Medicine Rhode Island Hospital 593 Eddy Street – Plain Street Building Room 123 Providence, RI 02903 Center on Systems, Outcomes & Quality in Chronic Disease & Rehabilitation Providence Veterans Affairs Medical Center 830 Chalkstone Avenue - Building 32 Providence, RI 02908-4799

Business Telephone Number: Rhode Island Hospital: (401) 444-3347 Providence VAMC: (401) 273-7100 x6240 Business Fax Number: Rhode Island Hospital: (401) 444-5040

Providence VAMC: (401) 457-3311

Electronic Mail Address: pfriedmann@lifespan.org peter.friedmann@va.gov EDUCATION Undergraduate Boston University 6-year Program in Liberal Arts and Medicine, Boston,

MA. 1981-1984. Concentration: Medical Science. B.A. 1988. Magna cum laude.

Medical School Boston University School of Medicine, Boston, MA. 1984-1988. M.D. 1988. Other Advanced Degrees Harvard School of Public Health, Boston, MA. 1992-1994. M.P.H. 1994.

Brown University, Providence, RI, M.A. ad eundem, May 2003. POSTGRADUATE TRAINING Residency: Montefiore Medical Center, Bronx, NY. Intern and Resident,

Primary Care Internal Medicine. 1988-1991. Fellowship: Faculty Development and Fellowship Program in General Internal Medicine

Harvard Medical School and New England Deaconess Hospital, Boston, MA. Clinical and Research Fellow. 1992-1994.

2

POSTGRADUATE HONORS AND AWARDS

The Leo M. Davidoff Society Award, "for outstanding achievement as a house officer in the teaching of medical students." Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY. 1990.

Primary Care Chief Resident. Montefiore Medical Center, Bronx, NY. 1990-1991. New Investigator/Educator Award, Association for Medical Education and Research in

Substance Abuse (AMERSA). 1999. Generalist Physician Faculty Scholar Award, The Robert Wood Johnson Foundation. 2000-

2004. Mentor, HRSA-AMERSA-CSAT/SAMHSA Interdisciplinary Program to Improve Health

Professional Education in Substance Abuse. 2000-2004. Finalist, Junior Investigator of the Year, Society of General Internal Medicine. 2001 Dean’s Teaching Excellence Award, Brown Medical School. In recognition of exemplary

teaching in Bio 301: Clerkship in Medicine Best Workshop Award, PRIMECare: Promote Recovery in Medical Care. 25th Annual National

Meeting of the Association for Medical Education and Research in Substance Abuse, November 8, 2001.

Semi-finalist, Best Abstract Award, "Maintenance care for alcohol problems in remission in

primary care." 26th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), November 7-9, 2002.

Bruce M. Selya Award for Research Excellence, Lifespan Hospitals, November 8, 2002. Mentor, ASAM Physician Clinical Support System (PCSS), a SAMHSA-funded network to

support physicians prescribing buprenorphine. 2005- Member, American Society of Addiction Medicine’s Expert Review Panel “Quality Care Best

Practice Models for the Treatment of Opioid Addiction Using Buprenorphine.” 2008. Member, Expert Consensus Panel. “Performance Indicators for Prison Health Care,”

RAND Corporation, Santa Monica, CA. July 21, 2009. Fellow, American Society of Addiction Medicine. 2010. Best Abstract Award, " Collaborative Behavioral Management reduces drug-related crime,

substance use among drug-involved parolees." 34th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), November 4-6, 2010.

Fellow, American College of Physicians. 2012. Board Member-Elect, American Board of Addiction Medicine & the ABAM Foundation, 2012-

3

PROFESSIONAL LICENSES AND BOARD CERTIFICATION

New York State License No. 179216. 1989. American Board of Internal Medicine, Certificate No. 135535. 1991-2001. Recertification, 2001-2011. Massachusetts License No. 76115. 1992. Illinois License No. 036-089324. 1994. American Society of Addiction Medicine, Certificate No. 022044. 1998-2009. American Board of Addiction Medicine, 2009-2020. Rhode Island License No. MD10110. 1999.

ACADEMIC APPOINTMENTS

Assistant Attending in Emergency Medicine. Albert Einstein College of Medicine, Bronx, NY. 1991-92. Assistant Professor of Medicine. Pritzker School of Medicine, University of Chicago. 1994-99.

Research Associate. Center for Health Administration Studies, University of Chicago. 1994-1999.

Research Associate. Population Research Center and Center on Aging, University of Chicago. 1994-1999.

Research Associate. National Opinion Research Center, University of Chicago. 1994-1999.

Core Faculty. Robert Wood Johnson Clinical Scholars Program, University of Chicago. 1994-1999.

Resource Faculty. Drug Abuse Research Center, University of Chicago. 1995-99. Research Associate. Graduate Program in Health Administration and Policy, U. of Chicago.

1995-1999.

Assistant Professor, Brown Medical School Departments of Medicine and Community Health. 1999-02. Associate Professor, Brown Medical School Departments of Medicine and Community Health, 2002-08 Professor, Research Scholar Track, Alpert Medical School of Brown University, Departments of

Medicine and Community Health, 2008-11. Professor, Research Scholar Track, Alpert Medical School of Brown University, Departments of

Medicine and Health Services, Policy and Practice, 2008-2011 Core Faculty, Fellowship in General Internal Medicine, Rhode Island Hospital / Brown

University. 1999-2002. Affiliated Faculty, Center for Alcohol and Addiction Studies, Brown University. 2002-. Affiliated Faculty, Center for AIDS Research, Brown University. 2004-. Director, Targeted Research Enhancement Program (TREP) in Health Services Research and

Development (HSR&D), Providence VA Medical Center. 2004-08 Director, Research Enhancement Award Program (REAP) in Health Services Research and

Development (HSR&D), Providence VA Medical Center. 2008-12. Director, Research Section, Division of General Internal Medicine. 2009-

4

HOSPITAL APPOINTMENTS

Staff Physician. North Central Bronx Hospital, Bronx, New York. 1991-92 Clinical Fellow. Manchester VAMC, Manchester, New Hampshire. 1992-94. Clinical Fellow. Deaconess Hospital, Boston, Massachusetts. 1992-94 Staff Physician. Malden Hospital, Malden, Massachusetts. 1992-93 Attending Physician. University of Chicago Medical Center. 1994-99. Attending Physician. Rhode Island and Miriam Hospitals. 1999-. Attending Physician. Providence Veterans Affairs Medical Center. 2004-.

OTHER APPOINTMENTS

Staff Physician. Harvard University Health Services, Cambridge, MA. 1993-94. Attending Physician. New City Health Center, Chicago, IL. 1995-96. Consultant Medical Director. Woodlawn Addiction Treatment Program, Chicago, IL. 1996-98. Special Emphasis Panel, AHCPR Small Project Grant Program. Agency for Health Care Policy and

Research, Rockville, MD. 1997. Member. Program Advisory Council. Chicago Schweitzer Urban Fellows Program. 1996-99. Consulting Staff Physician. Stanley Street Treatment and Resources. Fall River, MA. 1999-02. Guest Associate Editor, Journal of General Internal Medicine Special Issue-Substance Abuse:

Innovations In Primary Care. May 2002; Volume 17, No. 5. NIH Initial Review Group, Drug Abuse Health Services Research Subcommittee (NIDA-F).

National Institute on Drug Abuse, Rockville, MD. Ad Hoc Member 2003-2004. Permanent Member, 2004-2007.

President, Association for Medical Education and Research in Substance Abuse (AMERSA).

2007-2009. Vice-President and President-elect, 2005-2007. Treasurer 2003-2005. Speaker/Mentor Program, Reckitt Benckiser Pharmaceuticals, Inc. 2004-2009. Associate Editor, Alcohol and Health: Current Evidence. http://www.alcoholandhealth.org.

2003-2007. Associate Editor, Alcohol, Other Drugs and Health: Current Evidence.

http://www.aodhealth.org. 2007-2013. Special Emphasis Panel, NIDA 2004/10 “Screening and Intervention for Youth in Primary Care

Settings. Bethesda, MD. 2004.

5

Substance Use Disorders QUERI, Alcohol Misuse Workgroup. 2005-2010 Section Editor, Overview of Addiction Treatment, Principles of Addiction Medicine, 4th Edition.

Chevy Chase, MD: American Society of Addiction Medicine; 2008. Guest Editor (with FS Taxman), Journal of Experimental Criminology Special Issue - Tackling

Experimental Designs at Reentry Transition Points. September 2009; Volume 5, No. 3. Associate Editor, Journal of Substance Abuse Treatment. January 2009-. Editorial Boards, Substance Abuse & Rehabilitation, 2010-2012, Substance Abuse, 2010-. Member, CREATE & COIN Work Group. Health Services Research & Development Service,

Office of Research & Development, Veterans Health Administration. 2010-2011. Member, Special Emphasis Panel, Pilot Projects, Patient-Centered Outcome Research Institute.

Washington, DC. 2/22/2012. Chair, Special Emphasis Panel ZDA1 GXM-A (04), “Integration of DA Prevention & Treatment

in Primary Care Settings (R01)” NIDA/NIH . Bethesda, MD. 3/1/2012 Specialty Director, Internal Medicine, American Board of Addiction Medicine (ABAM) and the

ABAM Foundation (ABAMF). 2013-2016. Chair, Special Emphasis Panel/Scientific Review Group 2012/10 ZDA1 MXL-F (03) "Substance

Abuse Relapse Prevention” NIDA/NIH . Bethesda, MD. 5/22/2012.

HOSPITAL COMMITTEES

Member. Physician Assistance Committee. Medical Staff Organization, University of Chicago. 1996-99. Co-chair, Worksgroup on Critical Pathway for Sickle Cell Vasoocclusive Crisis. University of Chicago,

1995-96. Member, Research & Development Committee, Providence VA Medical Center, 2005- Associate Chair, 2011-

UNIVERSITY COMMITTEES

Member. Population Sciences Working Group, Task Force on Review and Revision of the Medical

School Curriculum, University of Chicago Pritzker School of Medicine. 1995-96. Member. Section of General Internal Medicine, University of Chicago, Clinician-Investigator

Faculty Search Committee. 1996-1999. Member. Strategic Planning Committee, Research Task Force. Graduate Program in Health

Administration & Policy. University of Chicago. 1997-99. Member. Pharmacoepidemiology Faculty Search Committee. Committee on Clinical

Pharmacology, University of Chicago. 1998-99. Member, Dissertation Committee.

6

Elizabeth Durkin, University of Chicago School of Social Service Administration, 1998-2002. Alexander Hoyt, Brandeis University Heller School for Social Policy and Management, 2005-12. Cori Kautz, Brandeis University, Heller School for Social Policy and Management, 2007-. Member, Resident Research Committee, Department of Medicine, Rhode Island Hospital and

Brown University. 1999-2002. Member. Research Faculty Search Committee, Division of General Internal Medicine, Rhode

Island Hospital and Brown University. 1999-. Chair, Academic Search Committee for Chief, Primary Care Service, Providence VA Medical

Center and Brown University. 2005-06. Member, Academic Search Committee for Chief, Mental Health and Behavioral Science

Service, Providence VA Medical Center and Brown University. 2005-07. 2010- Member, Academic Search Committee for Head, Section of Health Services Practice and Policy,

Department of Community Health, Alpert Medical School of Brown University. 2008-09. Vice-Chair, Medical Faculty Executive Committee, 2012-13. Chair, 2013-14. Past Chair 2014-15.

MEMBERSHIP IN SOCIETIES

American College of Physicians. 1989-2009. Society of General Internal Medicine. 1989-.

Substance Abuse Task Force. 1995-. Precourse Coordinator, “Reducing Substance Abuse in the Clinic and Community: The Role

of Primary Care,” 21st National Meeting. Chicago, IL. 1998. Abstract Selection Committee, 2006-.

Academy of Health Services Research. 1989-. American Public Health Association. 1995-2002. Association for Medical Education and Research in Substance Abuse (AMERSA). 1995-.

Program Committee, Abstract Selection Committee. 1997-. Chair, Abstract Selection Committee 1998-2000. Chair, Program Committee 2000-2002. Treasurer. 2003-2005, Vice-President. 2005-2007, President. 2007-2009

American Society of Addiction Medicine. 1995-.

Committee on Geriatric Substance Abuse. 1997-1999. Buprenorphine Training Subcommittee, Medications Development Committee, 2001-. Buprenorphine Trainer and Course Director, 2004-.

Society of Behavioral Medicine Member, Abstract Selection Committee. 1999-2000.

7

ORIGINAL PUBLICATIONS IN PEER-REVIEWED JOURNALS 1. Friedmann PD, Samore MH, Calkins DR. Clinical correlates of secondary meningitis in HIV-

infected adults. Arch Intern Med 1995;155:2231-2237. PMID: 7487246. 2. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists’ and cardiologists’

perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med 1996; 124:414-421. PMID: 8554250.

3. Woods KF, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C. Hospital utilization patterns

and costs for adult sickle cell patients in Illinois. Pub Health Rep 1997; 112:44-51. PMID: 9018288.

4. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist

physicians’ knowledge and use of angiotensin converting enzyme inhibitors for congestive heart failure. J Gen Intern Med 1997; 12:323-530. PMCID: PMC1497156.

5. Friedmann PD, Saitz R, Samet JH. Management of the patient recovering from alcohol or other

drug problems. Relapse prevention in primary care. JAMA 1998;279;1227-1231. PMID: 9555766.

6. Friedmann PD, Samore MH. Diagnostic characteristics of cerebrospinal fluid analysis for

secondary meningitis in HIV-infected adults. J Investig Med 1998;46:153-160. PMID: 9635375.

7. Friedmann PD, Alexander JA, D’Aunno TA. Organizational correlates of access to primary

care and mental health services in drug abuse treatment units. J Subst Abuse Treat 1998;16:71-80. PMID: 9888124.

8. Friedmann PD, Alexander JA, Jin L, D’Aunno TA On-site primary care and mental health

services in outpatient drug abuse treatment programs. J Behav Health Serv Res 1999; 26:80-94. PMID: 10069143.

9. Friedmann PD, Jin L, Karrison T, Nerney M, Cox Hayley D, Mulliken R, Walter J, Miller A,

Chin MH. The effect of alcohol abuse on the health status of older adults in the emergency department. Am J Alcohol Drug Abuse 1999;25 (3):529-542. PMID: 10473013.

10. Chin MH, Jin L, Karrison TG, Mulliken R, Cox Hayley D, Walter J, Miller A, Friedmann PD.

Older patients' health-related quality of life around an episode of emergency illness. Ann Emerg Med 1999; 34:595-603. PMID: 10533006.

11. Chin MH, Wang LC, Jin L, Mulliken R, Walter J, Cox Hayley D, Karrison TG, Nerney MP,

Miller A, Friedmann PD. Appropriateness of medication selection for older persons in the emergency department. Acad Emerg Med 1999; 6: 1235-1242. PMID: 10609925.

12. Friedmann PD, McCullough DM, Chin MH, Saitz R. Screening and intervention for alcohol

problems: a national survey of primary care physicians and psychiatrists. J Gen Intern Med 2000;15(2): 84-91. PMCID: PMC1495340.

8

13. Friedmann PD, Alexander JA, Jin L, D’Aunno TA. Medical and psychosocial services in outpatient drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res. 2000; 35(2): 443-465. PMID: 10857471.

14. Samet JH, Friedmann PD, Saitz R. Benefits of linking primary medical care and substance

abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161: 85-91. PMID: 11146702.

15. Friedmann PD, McCullough DM, Saitz R. Screening and intervention for illicit drug abuse: A

national survey of primary care physicians and psychiatrists. Arch Intern Med 2001; 161(2): 248-251. PMID: 11176739.

16. Friedmann PD, Mulliken R, Jin L, Karrison T, Cox Hayley D, Mulliken R, Walter J, Chin MH.

Early revisit, hospitalization or death among older persons discharged from the emergency department. Am J Emerg Med 2001; 19(2):125-129. PMID: 11239256.

17. Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D’Aunno TA. Linkage to medical

services in the Drug Abuse Treatment Outcome Study (DATOS). Med Care 2001;39:284-295. PMID: 11242322.

18. Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD. Validation of the Screening Strategy

in the NIAAA “Physicians’ Guide to Helping Patients with Alcohol Problems” J Stud Alcohol 2001; 62:234-238. PMID: 11332444.

19. Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among

methadone maintenance patients. Drug Alcohol Depend 2001; 64(1):47-53. PMID: 11470340. 20. Nerney MP, Chin MH, Jin L, Karrison TG, Walter J, Mulliken R, Miller A, Hayley DC,

Friedmann PD. Factors associated with older patients’ satisfaction with care in an inner-city emergency department. Ann Emerg Med 2001; 38:140-145. PMID: 11468608.

21. Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse

treatment. J Subst Abuse Treat 2001; 21: 97-103. PMCID: PMC1490248. 22. Stein MD, Anderson BJ, Charuvastra A, Friedmann PD. Alcohol use and sexual risk taking

among hazardously drinking drug injectors attending needle exchange. Alcohol Clin Exp Res. 2001; 25:1487-93. PMID: 11696669.

23. Stein MD, Anderson BJ, Charuvastra A, Sobota M, Friedmann PD. Alcohol and HIV risk

taking among intravenous drug users. Addict Behav 2002; 27:727-736. 24. McGarry KA, Stein MD, Clarke JG, Friedmann PD. Utilization of preventive health services by

HIV-seronegative injection drug users. J Addict Dis 2002; 21:93-102. PMID: 11916375.

25. Elliott L, Nerney M, Jones TE, Friedmann PD. Barriers to screening for domestic violence. J Gen Intern Med 2002;17:112-116. PMCID: PMC1495014.

26. Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. Patients’ use of the

internet for medical information. J Gen Intern Med 2002;17:180-185. PMCID: PMC1495021

9

27. Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treat. 2002; 22:23-32. PMID: 11849904.

28. Ballard Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein D. HIV prevention

services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev 2002; 14(2):117-125. PMID: 12000230.

29. Charuvastra A, Anderson BJ, Friedmann PD, Stein MD. Perceived addiction treatment needs

among alcohol using injection drug users. J Addict Dis. 2002; 21:93-107. PMID: 12296505.

30. Saitz R, Friedmann PD, Sullivan LM, Winter MR, Lloyd-Travaglini C, Moskowitz MA, Samet JH. Professional satisfaction caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med 2002; 17: 373-376. PMCID: PMC1495049

31. Stein MD, Friedmann PD. Need for medical and psychosocial services among injection drug

users: a comparative study of needle exchange and methadone maintenance. Am J Addict 2002; 11:262-270. PMID: 12584869.

32. Shah MN, Glushak C, Karrison TG, Mulliken R, Walter J, Friedmann PD, Cox Hayley D, Chin

MH. Predictors of emergency medical service utilization by elders. Acad Emerg Med. 2003; 10:52-58. PMID: 12511315.

33. Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. The effect of primary medical

care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003;18:1-8. PMCID: PMC1494811.

34. Friedmann PD, Lemon S, Anderson BJ, Stein MD. Predictors of follow-up health status in the

Drug Abuse Treatment Outcome Study (DATOS). Drug Alc Depend. 2003; 69(3):243-251. PMID: 12633910.

35. Friedmann PD, Lemon S, Durkin E, D’Aunno TD. Trends in comprehensive service

availability in outpatient drug abuse treatment. J Subst Abuse Treat. 2003; 24(1): 81-88. PMID: 12646334.

36. Friedmann PD, Lemon S, Stein MD, D'Aunno TA. Community referral sources and entry of

treatment-naïve clients into outpatient addiction treatment. Am J Drug Alc Abuse. 2003; 29(1):105-115. PMID: 12731683.

37. Friedmann PD, Herman DS, Freedman S, Lemon SC, Ramsey S, Stein MD. Treatment of sleep

disturbance in alcohol recovery: A national survey of addiction medicine physicians. J Addict Dis. 2003; 22(2): 91-103. PMCID: PMC2761628.

38. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and

improvement in drug use. Addiction. 2003; 98:673-684. PMID: 12751985. 39. Kertesz S, Horton N, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door:

stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat. 2003; 24(3):197-207. PMID: 12810140.

10

40. Friedmann PD, Lemon S, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003; 38(3): 887-903. PMCID: PMC1360921

41. Warner EA, Walker RM, Friedmann PD. Should informed consent be required for laboratory

testing for drugs of abuse in medical settings? Am J Med. 2003; 115:54-58. PMID: 12867235. 42. Lemon SC, Friedmann PD, Stein MD. Impact of smoking cessation on drug abuse treatment

outcome. Addict Behav. 2003; 28(7):1323-1331. PMID: 12915172. 43. Allen SA, Rich JD, Schwartzapfel B, Friedmann PD. Hepatitis C among offenders: correctional

challenge and public health opportunity. Federal Probation. 2003; 67(2):22-26. 44. Lemon SC, Clark MA, Roy J, Friedmann PD, Rakowski W. Classification and regression tree

analysis in public health: Methodologic review and comparison with logistic regression. Ann Behav Med. 2003;26(3):172-181. PMID: 14644693.

45. Friedmann PD, Hendrickson J, Gerstein DR, Zhang Z. Designated case managers as facilitators

of medical and psychosocial service delivery in addiction treatment programs. J Behav Health Serv Res. 2004;31(1):86-97. PMID: 14722483.

46. Lemon SC, Rakowski W, Clark MA, Roy J, Friedmann PD. Variations in influenza vaccination

among the elderly. Am J Health Behav. 2004;28(4):352-360. PMID: 15228972. 47. Friedmann PD, Hendrickson J, Zhang Z, Gerstein DR. The effect of matching comprehensive

services to patients’ needs on drug use improvement in addiction treatment. Addiction. 2004;99:962-972. PMCID: PMC2761625.

48. Vassilev ZP, Strauss SM, Astone JM, Friedmann PD, Des Jarlais DC. Provision of on-site

medical treatment to patients with hepatitis C in drug treatment units. J Health Care Poor Underserv 2004. 15(4): 663-671. PMID: 15531822.

49. Christensen MH, Boisse N, Sanchez W, Friedmann PD. Enhancing vocational rehabilitation

counselors’ substance abuse screening, assessment and intervention practices. J Vocational Rehab. 2004;21:157-163.

50. Charuvastra A, Friedmann PD, Stein MD. Physician attitudes regarding the prescription of

medical marijuana. J Addict Dis 2005. 24(3):87-93. PMID: 16186085.

51. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. J Gen Intern Med. 2005; 2(11): 1038-41. PMCID: PMC1490248.

52. Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD, Attitudes

and practices regarding the use of methadone in state and federal prisons. J Urban Health. 2005 82(3):411-419. PMID: 15917502.

53. Friedmann PD, Hendrickson J, Gerstein D, Zhang Z, Stein MD. Do mechanisms that link

addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006: 44(1):8-15. PMID: 16365607.

11

54. Stein MD, Friedmann PD. Disturbed sleep and its relation to alcohol use. Substance Abuse. 2005; 26(1):1-13. PMCID: PMC2775419.

55. Christensen MH, Boisse N, Sanchez W, Friedmann PD. Teaching substance abuse screening,

assessment and brief intervention to vocational rehabilitation counselors. Substance Abuse. 2005;26(3/4):59-62. PMID: 16837416.

56. Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack H. Duration of outpatient

nonmethadone treatment::results from a national survey. Substance Abuse. 2006; 27(3) 45-51. PMID: 17135180.

57. Friedmann PD, Rose J, Hayaki J, Ramsey S, Charuvastra A, Dubé C, Herman D, Stein MD.

Training primary care clinicians in maintenance care for moderated alcohol use. J Gen Intern Med. 2006; 21:1269-1275. PMCID: PMC1924751.

58. Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedmann P, Sharma SC. Pharmacist-led

cardiac risk reduction model. Prevent Cardiol. 2006; 9: 202-208. PMID: 17085982. 59. Stein MD, Anderson BJ, Lassor J, Friedmann PD. Receipt of disability payments for substance

users: mental and physical health correlates. Am J Addict. 2006; 15:160-165. PMID: 16595354. 60. Friedmann, PD, Taxman FS, Henderson CE. Evidence-based treatment practices for drug-

involved adults in the criminal justice system. J Subst Abuse Treat. 2007;32:267-77. PMCID: PMC1885209.

61. Sacks S, Melnick G, Coen C, Banks S, Friedmann PD, Grella C, Knight K. CJDATS Co-

occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): a pilot study. The Prison Journal. 2007; 87 (1):86-110. PMCID: PMC3227556

62. Wu WC, Schiffner T, Henderson W, Eaton CB, Poses RM Uttley G, Sharma SC, Vezeridis M,

Khuri SF, Friedmann PD. Levels of preoperative hematocrit predict postoperative cardiovascular and fatal outcomes in elderly patients undergoing major non-cardiac surgery. JAMA. 2007;297:2481-2488. PMID: 17565082.

63. Sacks S, Melnick G, Coen C, Banks S, Friedmann PD, Grella C, Knight K, Zlotnick. CJDATS

Co-occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): a validation study. Criminal Justice and Behavior. 2007; 34 (9):1198-1215. PMCID: PMC3184768.

64. Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance

abuse treatment programs in the United States. J Subst Abuse Treat. 2008;34: 165– 172. PMID: 17509809

65. Hatgis C, Friedmann PD, Wiener M. Attributions of responsibility for addiction: the effects of

gender and type of substance. Subst Use Misuse. 2008;43:700–708. PMID: 18393084. 66. Zhang Z, Friedmann PD, Gerstein DR. Patient satisfaction and sustained outcomes of drug abuse

treatment. J Health Psychol.2008;13(3);388-400. PMCID: PMC2796692. 67. Hebert MR, Clarke JG, Caviness CM, Ray MK, Friedmann PD, Stein MD. Feasibility of

accessing women in jail for health interventions. Women Health. 2008 ;47 (3):79-93. PMID: 18714713

12

68. Friedmann PD, Katz EC, Rhodes AG, Taxman FS, O’Connell DJ, Frisman LK, Burdon WM,

Fletcher BW, Litt MD, Martin SS. Collaborative behavioral management for drug-involved parolees: Rationale and design of the Step’n Out Study. J Offender Rehabil. 2008; 47(3): 290–318. PMCID: PMC2756716.

69. Friedmann PD, Melnick G, Jiang L, Hamilton Z. Violent and disruptive behavior among drug-

involved prisoners: relationship with psychiatric symptoms. Behav Sci Law. 2008; 26:389-401. PMCID: PMC2761621.

70. Zlotnick C, Clarke JG, Friedmann PD, et al.. Gender differences in comorbid disorders among

offenders in a prison substance abuse treatment program. Behavioral Sci Law. 2008; 26:403-412. PMID: 18683199.

71. Friedmann PD, Rose JS, Swift R, Stout R, Millman RP, Stein MD. Trazodone for sleep

disturbance after alcohol detoxification. Alc Clin Exp Res. 2008; 32(9): 1652-1660. PMCID: PMC2567128.

72. Rhodes AG, Taxman FS, Friedmann PD, Cropsey KL. HCV in incarcerated populations: an

analysis of gender and criminality on risk. J Psychoactive Drugs. 2008;40(4):493-501. PMID: 19283953.

73. Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C.

Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behavioral Sci Law. 2009;27(1):51-69. PMCID: PMC2761624.

74. Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz R.

Update in addiction medicine. J Gen Intern Med. 2009; 23(12):2112–6. PMCID: PMC2596507. 75. Stein MD, Anderson BJ, Caviness CM, Rosengard C, Kiene S, Friedmann P, Clarke JG.

Relationship of alcohol use and sexual risk taking among hazardously drinking incarcerated women: an event-level analysis. J Stud Alcohol Drugs. 2009; 70: 508-515. PMCID: PMC2696291.

76. Caviness CM, Hatgis C, Anderson BJ, Rosengard C, Kiene SM, Friedmann PD, Stein MD.

Three brief alcohol screens for detecting hazardous drinking in incarcerated women. J Stud Alcohol Drugs. 2009; 0(1):50-4. PMCID: PMC2629634.

77. Chuang E, Wells R, Alexander JA, Friedmann PD, Lee I-H. Factors associated with use of

ASAM criteria and service provision in a national sample of outpatient substance abuse treatment units. J Addict Med. 2009; 3:139-150.

78. Friedmann PD, Rhodes AG, Taxman FS, et al. Collaborative behavioral management: integration

and intensification of parole and outpatient addiction treatment services in the Step’n Out study. J Exp Criminol. 2009; 5: 227-244. PMCID: PMC2786218.

79. Ramsey SE, Engler PA, Harrington M, Smith RJ, Fagan MJ, Stein MD, Friedmann P. Brief

alcohol intervention among at-risk drinkers with diabetes. Substance Abuse: Research and Treatment 2010; 4:1-8. PMCID: PMC2841352.

13

80. Friedmann PD, Jiang L, Alexander JA. Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs. J Behav Health Serv Res. 2010;37(3): 322-37.

81. Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SAM, Pirraglia P, Wu WC.

Pharmacist-led group medical intervention in type II diabetes. Diabetes Educ. 2010;36(1):109-17. 82. Wu W-C, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G, Mor V, Sharma SC,

Vezeridis M; Khuri SF, Friedmann PD. Operative blood loss, blood transfusion and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010;252:11-17.

83. Stein M, Herman DS, Kettavong M, Cioe PA, Friedmann P, Tellioglu T, Anderson BJ.

Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. J Subst Abuse Treat. 2010;39(2):157-166. PMCID: PMC2910850.

84. Cioe P, Stein MD, Friedmann PD. Erectile dysfunction in opioid users: lack of association with

serum testosterone. J Addict Dis. 2010; 29(4):455-460. PMCID: PMC2951625. 85. Greenberg PB, Liu J, Wu WC, Jiang L, Tseng V, Scott IU, Friedmann PD. Predictors of mortality

within 90 days of cataract surgery. Ophthalmol.2010; 117(10) 1894-1899. 86. O'Toole TP, Buckel L, Bourgault C, Blumen J, Redihan SG, Jiang L, Friedmann P. Applying the

chronic care model to homeless veterans: effect of a population approach to primary care on utilization and clinical outcomes Am J Pub Health. 2010;100:2493-2499.

87. Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and Treatment

Response in the Step’n Out Study of Substance-Use Treatment Mandated Parolees. J Substance Abuse Treat. 2011; 40: 313-321. PMCID: PMC3056944.

88. Greenberg PB, Tseng V, Liu J, Wu W-C, Jiang L, Scott IU, Friedmann PD. Prevalence and

predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology 2011. 118(3):507-514.

89. Pirraglia PA, Kilbourne AM, Lai Z, Friedmann PD, O’Toole TP. Colocated General Medical

Care and Preventable Hospital Admissions for Veterans with Serious Mental Illness. Psychiatric Services 2011. 62(5):554-557.

90. Tseng VL, Greenberg PB, Wu WC, Jiang L, Kang JM, Scott IU, Friedmann PD. Cataract surgery

complications in nonegenarians. Ophthalmology. 2011. 118(7):1229-35.

91. Clarke JG, Martin RA, Stein LAR, Lopes C, Mello J, Friedmann PD, Bock BC. Working inside for smoking elimination (W.I.S.E.) study design and rationale to prevent return to smoking after release from a smoke free prison. BMC Public Health 2011;11: 767.PMCID: PMC3213245.

92. Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh

WN, Stein LAR, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK for the MAT Working Group of CJ-DATS. Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): availability, barriers & intentions. Substance Abuse 2012. 33:9–18. PMCID: PMC3295578

14

93. Coviello DM, Cornish JW, Lynch KG, Boney T, Clark C, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, O’Brien CP. A multi-site pilot study of depot naltrexone treatment for opioid-dependent offenders. Substance Abuse 2012. 33:48–59.

94. McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Substance Abuse 2012. 33:19–29. PMCID: PMC3278074.

95. Rudes DS, Taxman FS, Portillo S, Murphy A, Rhodes A, Stitzer M, Luongo P, Friedmann PD.

Adding positive reinforcements in justice settings: acceptability & feasibility. J Subst Abuse Treat. 2012; 42: 260–270.

96. Wu WC, Trivedi A, Friedmann PD, Henderson WG, Smith TS, Poses RM, Uttley G, Vezeridis

M, Eaton CB, Mor V. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg. Ann Surg. 2012;255(4):708-714.

97. Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment

provided during drug treatment? J Subst Abuse Treat. 2012; 42(1):4-15.

98. Friedmann PD, Green TC, Taxman FS, Harrington M, Rhodes AG, Katz E, O'Connell D, Martin SS, Frisman LK, Litt M, Burdon W, Clarke JG, Fletcher BW; for the Step’n Out Research Group of CJ-DATS. Collaborative behavioral management in parole and outpatient addiction treatment: drug use, crime and arrest outcomes in the Step’n Out study. Addiction. 2012; 107: 1099–1108. PMCID: PMC3321077.

99. Green TC, Pouget ER, Harrington M, Rhodes AG, O’Connell D, Martin SS, Prendergast M, Friedmann PD. Limiting options: Sex ratios, incarceration rates and sexual risk behavior among people on probation and parole. Sex Transmit Dis. 2012; 39(6); 424-30.

100. Richter KP, Hunt JJ, Cupertino AP, Garrett S, Friedmann PD. Understanding the drug

treatment community’s ambivalence towards tobacco use and treatment. Int J Drug Policy. 2012;23(3):220-8.

101. Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths

among former inmates. J Addict Med. 2012; 6:97-105.

102. Pirraglia P, Rowland E, Taveira T, Cohen L, Wu WC, Friedmann PD, O'Toole TP. The benefits of a primary care clinic co-located and integrated in the mental health setting for veterans with serious mental illness. Prevent Chronic Dis. 2012; 9: E51. PMCID: PMC3340211.

103. Green TC, Johnson J, Harrington M, Pouget ER, Rhodes AG, Taxman FS, O’Connell DJ,

Martin SS, Prendergast M, Friedmann PD. Parole officer-parolee relationships and HIV risk behaviors during community supervision. AIDS Behav. In Press.

104. Li E, Greenberg PB, Tseng V, Caffrey AR, Woodmansee SB, Wu WC, Friedmann PD,

LaPlante KL. In vitro coagulation effects of ophthalmic doses of bevacizumab. J Ocular Pharmacol Therap. In press.

15

105. Taylor LE, Maynard MA, Friedmann PD, MacLeod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for HIV/HCV coinfected patients: does it serve as a bridge to HCV therapy? J Addict Med. In Press.

106. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann

PD. How does use of a prescription monitoring program change medical practice? Pain Medicine. In Press.

OTHER PEER-REVIEWED PUBLICATIONS 1. Saitz R, Friedmann PD, Roberts MS. Continued zidovudine or didanosine for human

immunodeficiency virus infection (Letter). N Engl J Med. 1992;327(22):1598. 2. Stein MD, Friedmann PD. Generalist physicians and addiction care: from turfing to sharing the

turf. (Editorial). JAMA 2001; 286: 1764-1765. 3. Stein MD, Friedmann PD. Optimizing opioid detoxification: rearranging deck chairs on the

Titanic (Editorial). J Addict Dis 2007; 26(2): 1-2. 4. Warner EA, Friedmann PD. Laboratory testing for drug abuse (Letter). Arch Pediatr Adolesc

Med. 2006;160(8):854. 5. Taxman FS, Friedmann PD. Fidelity and adherence at the transition point: theoretically driven

experiments (Editorial). J Exp Criminol. 2009; 219-226. 6. Friedmann PD, Saitz R, Vaillancourt D. Sensitivity/specificity of alcohol amounts in seniors

(Letter). Addiction. 2010; 5: 568.

7. Green TC, Zaller N, Rich J, Bowman S, Friedmann P. Revisiting Paulozzi et al.’s “Prescription drug monitoring programs and death rates from drug overdose” (Letter). Pain Medicine. 2011; 12(6):982-5.

8. Friedmann PD, Schwartz RP. Just call it "treatment". Addiction Sci Clin Pract. 2012; 7:10.

Friedmann PD, Saitz R, Samet JH. Linking addiction treatment with other medical and psychiatric treatment systems. Chapter 8. Principles of Addiction Medicine, 3rd Edition. Chevy Chase, MD: American Society of Addiction Medicine; 2003; pp. 497-507.

BOOKS OR BOOK CHAPTERS

Friedmann PD, Phillips K, Saitz R, Samet JH. Linking addiction treatment with other medical and psychiatric treatment systems. Principles of Addiction Medicine, 4th Edition. Chevy Chase, MD: American Society of Addiction Medicine; 2008. Friedmann PD, Cioe P. Clinical management II. Chapter 8. Buprenorphine: A Clinical Manual. American Psychiatric Publishing; 2010. Cottler L, Flynn P, Friedmann P, Harachi T. Mentoring: A Guide for Drug Abuse Researchers. NIH Publication No. 09-5770. Rockville, MD: National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services; 2009.

16

Doyle TJ, Zywiak WH, Friedmann PD. Management of patients with alcohol dependence in recovery: options for maintenance and anticipating and managing relapse in primary care. In R Saitz, ed. Addressing Unhealthy Alcohol Use in Primary Care. New York: Springer; 2012. OTHER NON-PEER-REVIEWED PUBLICATIONS 1. Friedmann PD. Forgotten values. Boston University Centerscope 1988;2:15-16.

2. Saitz R, Friedmann PD, Roberts MS. Continued zidovudine or didanosine for human

immunodeficiency virus infection. (Letter). N Engl J Med 1992;327: 1598. 3. Friedmann PD. Review of Duesberg PH, Inventing the AIDS virus. Persp Biol Med

1994;40:467-469. 4. Friedmann PD. Review of Andrews LJ, Novick LB, HIV Care: A Comprehensive Handbook for

Providers. Doody’s Health Sciences Book Review Journal 1995; Vol. 3, No. 1. 5. Friedmann PD. Review of Jones R, Kinmouth AL, Critical Reading for Primary Care. Doody’s

Health Sciences Book Review Journal 1995; Vol. 3, No. 2. 6. Friedmann PD, Charuvastra A, Herman DS, Dube C, DeSantiago S, Freedman S, Stein MD.

PRIMECare. Promote Recovery in Medical Care. A Guideline for the Maintenance Care of Medical Patients in Recovery from Alcohol Abuse or Dependence. Providence, RI: Division of General Internal Medicine, Rhode Island Hospital, 2001.

7. Friedmann PD, Charuvastra A, Herman DS, Dube C, Stein MD. Recovery Workbook.

PRIMECare. Promote Recovery in Medical Care. Providence, RI: Division of General Internal Medicine, Rhode Island Hospital, 2001.

8. Friedmann PD, Cioe PA, Stein MD. Buprenorphine’s promise (commentary). Brown

University Digest of Addiction Theory and Application (DATA). 2004; 23(5):8. Providence, RI: Manisses Publications; May 2004.

9. Friedmann PD. Does drinking frequency—more than average consumption—influence

mortality? Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2004.

10. Friedmann PD. Primary care brief intervention works equally well in women and men. alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2004.

11. Friedmann PD. Does experience influence hospitals' resource use in treating alcohol and other

drug diagnoses? Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); July-August 2004.

12. Friedmann PD. Drinking patterns — not just total amount — affect risk of coronary heart

disease and total mortality. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); July-August 2004.

13. Friedmann PD. Safer drinking recommendations should vary by age and sex. alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); September-October 2004.

17

14. Friedmann PD. Collaborative care reduces alcohol problems and ptsd in trauma patients. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); September-October 2004.

15. Friedmann PD. Don't blame substance use for mood and anxiety disorders. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); November-December 2004. 16. Friedmann PD. Geography, sociodemographic factors, and the risk of substance use disorders.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2004.

17. Friedmann PD. Recent drinking doubles the risk of injury. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2005.

18. Friedmann PD. Prevalence of alcohol dependence without symptoms of abuse. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); January-February 2005. 19. Friedmann PD. Primary medical care improves addictive problems. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); March-April 2005. 20. Friedmann PD. Adolescent drinking portends early adult harms. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); March-April 2005. 21. Friedmann PD. Brief counseling at regular office visits reduces drinking for 1 year. Alcohol,

Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2005. 22. Friedmann PD. AUDIT and CRAFFT outperform cage in screening young people. Alcohol,

Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2005. 23. Friedmann PD. Computerized brief intervention decreases drinking and consequences. Alcohol,

Other Drugs, and Health: Current Evidence (AODHealth.org); July-August 2005. 24. Friedmann PD. Inherited differences in metabolism influence risk of alcohol dependence.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); July-August 2005. 25. Friedmann PD. Impaired control scale predicts outcome of alcohol moderation. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); September-October 2005. 26. Friedmann PD. Alcohol as analgesic: older drinkers numb the pain. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); September-October 2005.

27. Friedmann PD. Abstainers and coronary heart disease: are unknown risk factors to blame? Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2005.

28. Friedmann PD. Elders with alcohol dependence receive less aftercare. Alcohol, Other Drugs,

and Health: Current Evidence (AODHealth.org); November-December 2005. 29. Friedmann PD. Heart and mind: Is moderate alcohol consumption good for your brain, too?

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2006.

18

30. Friedmann PD. The validity of biomarkers in detecting alcohol dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2006.

11. Friedmann PD. Moderate alcohol use lowers diabetes risk in older woman. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); March-April 2006. 12. Friedmann PD. Alcohol-related diagnoses increase resource use by hospitalized seniors.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); March-April 2006. 13. Friedmann PD. Remission and relapse in the general population. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); May-June 2006. 14. Friedmann PD. Natural remission and relapse. Alcohol, Other Drugs, and Health: Current

Evidence (AODHealth.org); May-June 2006. 15. Friedmann PD. Intensive referral to 12-step groups improves outcomes. Alcohol, Other Drugs,

and Health: Current Evidence (AODHealth.org); July-August 2006. 16. Friedmann PD. Help seeking quadruples the likelihood of abstinence. Alcohol, Other Drugs,

and Health: Current Evidence (AODHealth.org); July-August 2006. 17. Friedmann PD and Guerriero RT. Most medical inpatients with unhealthy alcohol use have

dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); July-August 2006.

18. Friedmann PD. Unhealthy drinking and comorbidity in American Indians. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); September-October 2006. 19. Friedmann PD. Injury risk is higher in countries with riskier drinking patterns. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); September-October 2006. 20. Friedmann PD. Alcohol outlets increase hospitalizations for assault. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); November-December 2006. 21. Friedmann PD. Primary care clinicians lack comfort and skills in discussing alcohol use.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2006.

22. Friedmann PD. As per capita alcohol consumption increases, so does sickness absence.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2007. 23. Friedmann PD. Naltrexone with compliance therapy is no better than placebo for alcoholism.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2007. 24. Friedmann PD. All relapses are not the same. Alcohol, Other Drugs, and Health: Current

Evidence (AODHealth.org); March-April 2007. 25. Friedmann PD. Follow-up assessment reduces drinking. Alcohol, Other Drugs, and Health:

Current Evidence (AODHealth.org); March-April 2007.

19

26. Friedmann PD. Brief intervention is insufficient for medical inpatients with unhealthy drinking. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2007.

27. Friedmann, PD. Benzodiazepine use in patients receiving opioid treatment. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); May-June 2007. 28. Friedmann PD. Unhealthy alcohol use and the preventive paradox. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); July-August 2007. 29. Friedmann PD. Coordinated treatment for hepatitis C in injection drug users. Alcohol, Other

Drugs, and Health: Current Evidence (AODHealth.org); July-August 2007. 30. Friedmann PD. Health plans’ requirements for mental health and substance use screening.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); September-October 2007.

31. Friedmann PD. Divorce: grounds for substance use screening. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); September-October 2007. 32. Friedmann PD. Brief MI in emergency rooms reduces problem drinking in young adults.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2007.

33. Friedmann PD. Training generalist physicians improves confidence in treating opiate misuse.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2007.

34. Friedmann PD. The “Clinician’s Illusion” and SBIRT (commentary). Brown University Digest

of Addiction Theory and Application (DATA). 2008; 27(7):8. New York: Wiley InterScience. 35. Friedmann PD. Melatonin, benzodiazepines, and sleep quality among patients receiving

methadone. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-March 2008.

36. Friedmann PD. Methadone maintenance plus syringe exchange reduces HIV and HCV

incidence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-March 2008.

37. Friedmann PD. Similar outcomes from observed and unobserved dosing of buprenorphine-

naloxone. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); April 2008. 38. Friedmann PD. Opioid maintenance therapy saves lives. Alcohol, Other Drugs, and Health:

Interventions and Assessments (AODHealth.org); May-June 2008. 39. Friedmann PD. The impact of peer and parental modeling on impaired driving in teenagers.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2008. 40. Friedmann PD. Prescription drug misuse is prevalent and associated with youth, psychiatric

problems, and other substance use. Alcohol, Other Health: Current Evidence (AODHealth.org); July-August 2008.

20

41. Friedmann PD. Youth cannabis use commonly extends into adulthood. Alcohol, Other Health: Current Evidence (AODHealth.org); July-August 2008.

42. Friedmann PD. Buprenorphine with drug counseling is superior to oral naltrexone with

counseling or counseling alone for heroin dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); September-October 2008.

43. Friedmann PD. Universal screening, assessment, and treatment of substance use at prenatal

visits improves obstetric outcomes. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); September-October 2008.

44. Friedmann PD. Overdose management training and take-home naloxone for opiate-using

persons may save lives. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); November-December 2008.

45. Friedmann PD. Alcohol counseling can reduce blood pressure. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); November-December 2008. 46. Friedmann PD. Confidence and judgment are important for medical management of alcohol

dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2009.

47. Friedmann PD. Topiramate shows potential for treatment of alcohol dependence. Alcohol,

Other Drugs, and Health: Current Evidence (AODHealth.org); January-February 2009. 48. Friedmann PD. Brief intervention in the hospital may reduce prescription drug misuse. Alcohol,

Other Drugs, and Health: Current Evidence (AODHealth.org); March-April 2009. 49. Friedmann PD. Brief family treatment in primary care might lessen the burden of having an

addicted relative. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); March-April 2009.

50. Friedmann PD. Quarterly recovery management checkups to treat chronic substance use

disorders. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2009.

51. Friedmann PD. Repeated brief counseling decreases recurrence of alcohol-related pancreatitis.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2009. 52. Friedmann PD. Alcohol consumption limits associated with alcohol problems in older adults.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Sept-Oct 2009. 53. Friedmann PD. New cocaine vaccine is safe but has limited efficacy. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); Nov-Dec 2009. 54. Friedmann PD. Single-question alcohol screen detects unhealthy alcohol use in a primary care

setting. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Nov-Dec 2009. 55. Friedmann PD. My take: Research needed on medicinal uses (of marijuana). Internal Medicine

News 2010; 45 (3): 82.

21

56. Friedmann PD. Sustained-release dexamphetamine maintenance for methamphetamine dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Jan-Feb 2010.

57. Friedmann PD. Internet-based intervention reduces alcohol use. Alcohol, Other Drugs, and

Health: Current Evidence (AODHealth.org); Jan-Feb 2010.

58. Friedmann PD. My take: Budget proposal favors interdiction. Internal Medicine News 2010; 43 (11): 2.

59. Friedmann PD. VA Relaxes Burden of Proof to Qualify for PTSD Treatment. My take: Policy

will cut paperwork, delays. Internal Medicine News 2010; 43(13):2.

60. Friedmann PD. Does early cannabis use lead to psychosis. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); July-Aug 2010.

61. Friedmann PD. Motivational enhancement more effective than cognitive behavioral therapy for

alcoholics with low motivation. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Nov-Dec 2010.

62. Friedmann PD. Age under 65 and history of a psychiatric or opioid use disorder are associated

with a current prescription opioid use disorder. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Nov-Dec 2010.

63. Friedmann PD. The association of cannabis use with onset of psychosis: still controversial.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2011.

64. Friedmann PD. Preoperative unhealthy alcohol use increases surgical risk. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2011.

65. Friedmann PD. Buprenorphine-naloxone works for prescription opioid dependence as long as it

is maintained. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Nov-Dec 2011.

66. Friedmann PD. Patients who receive opioids for chronic pain are inadequately managed.

Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Nov-Dec 2011. 67. Friedmann PD. Retention in opioid agonist treatment after prison release reduces re-

incarceration. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Jan-Feb 2012.

68. Friedmann PD. Thirty years of observational studies of alcohol’s cardioprotective effects:

uncertainty remains. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); Jan-Feb 2012.

69. Friedmann PD. Severity of alcohol problems predicts recurrence and persistence of alcohol

dependence. Alcohol, Other Drugs, and Health: Current Evidence (AODHealth.org); May-June 2012.

PUBLICATIONS IN PREPARATION OR SUBMITTED

22

Rhodes AG, Taxman FS, Rose J, Friedmann PD. Rapport between parole officers and offenders: effects on drug use and criminal justice outcomes. Criminol. Submitted. Frank J, Andrews C, Green TC, Samuels A, Trinh TT, Friedmann PD. Emergency department use for substance use conditions among ex-prisoners. In preparation. Andrews C, Friedmann PD, Green TC, et al. Effect of collaborative behavioral management on employment outcomes in the Step’n Out study. In preparation. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change pharmacy practice? J Am Pharmacy Assoc. Submitted.

ABSTRACTS 1. Friedmann PD, Samore MH, Calkins DR. Clinical prediction of meningitis in persons with

advanced immunodeficiency virus (HIV) infection. J Gen Intern Med. 1994;9 (Suppl 2):29. Oral presentation.

2. Friedmann PD, Brett AS, Mayo-Smith MF. Physicians overestimate risk of cardiovascular disease and benefit of preventive therapies. J Gen Intern Med. 1994;9 (Suppl 2):87. Poster presentation.

3. Friedmann PD, Alexander JA. Clients’ age and access to primary care services in the 1995 wave of the National Drug Abuse Treatment System Survey. Abstract book: Association for Health Services Research 13th Annual Meeting, June 9-11, 1996:162. Poster presentation.

4. Chin MH, Friedmann PD, Cassel CK, Lang RM. Variations in the use of ACE inhibitors by generalist physicians and cardiologists caring for heart failure patients. J Gen Intern Med 1996; 11 (Suppl 1):66.

5. Cox Hayley D, Karrison T, Walter J, Miller A, Mulliken R, Chin M, Friedmann P. Elderly in the emergency department who have inadequate social support. Annual Meeting of the American Geriatrics Society, May 7-11, 1997.

6. Chin MH, Mulliken R, Walter J, Cox-Hayley D, Karrison T, Miller A, Cassel CK, Friedmann PD. Characteristics and outcomes of older persons presenting to an inner city emergency department. J Gen Intern Med 1997; 12 (Suppl 1):118.

7. Friedmann PD, Alexander JA, D’Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Abstracts from the Association for Health Services Research 14th Annual Meeting June 16, 1997:162. Poster presentation.

8. Nerney M, Chin M, Jin L, Karrison T, Cox Hayley D, Walter J, Mulliken R, Miller A, Friedmann P. Factors associated with older patients' satisfaction with care in an inner-city emergency department. J Investig Med 1997; 45:347A.

9. Friedmann PD, Jin L, Nerney M, Mulliken R, Walter J, Cox Hayley D, Miller A, Chin MH. The effect of problem drinking on health outcomes of elderly patients in the emergency department. J Invest Med 1997; 45:312A. Poster presentation.

23

10. Friedmann PD, Alexander JA, D’Aunno TA. Organizational correlates of access to primary care

and mental health services in drug abuse treatment units. J Invest Med 1997; 45:312A.

11. Friedmann PD, Alexander JA, D’Aunno TA. Linkages to primary care and mental health services in outpatient substance abuse treatment units. Abstracts of the American Public Health Association 125th Annual Meeting, November 12, 1997. Oral presentation.

12. Friedmann PD, Jin L, Mulliken R, Walter J, Cox Hayley D, Miller D, Chin MH. The effect of problem drinking on health outcomes of elderly patients in the emergency department. Substance Abuse 1998;19:133. Poster presentation.

13. Friedmann PD, Alexander JA, D’Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Substance Abuse 1998;19:141. AMERSA Oral presentation.

14. Wang LC, Jin L, Nerney M, Mulliken R, Walter J, Friedmann PD, Cox Hayley D, Karrison TG, Miller A, Chin MH. Appropriateness of medication selection for older persons in the emergency department. J Gen Intern Med 1998;13 (suppl):41.

15. Friedmann PD, Jin L, Polonsky T, Chin MH. Screening for alcohol abuse by adult primary care physicians and psychiatrists. J Gen Intern Med 1998;13 (suppl):102. Poster presentation.

16. Elliott L, Jones TE, Nerney M, Friedmann PD. Barriers to universal screening for domestic violence. J Gen Intern Med 1998;13 (suppl):121. Oral presentation.

17. Friedmann PD, Alexander JA, Jin L, D’Aunno TA. Linkage to ancillary medical and psychosocial services in outpatient drug abuse treatment. Substance Abuse 1999;20:186-187. Oral presentation.

18. Friedmann PD, Zhang JX, Pittinger C, Brooks AR, Saitz R. Does an open-ended introduction or question-order influence the test characteristics of alcohol screening tools? J Gen Intern Med 1999;14 (suppl 2):31. Poster presentation.

19. Saitz R, Friedmann PD, Sullivan LM, Winter MR, Lloyd-Travaglini CA, Moskowitz MA, Samet JH. Professional satisfaction and attitudes of faculty and housestaff caring for patients with substance abuse. J Gen Intern Med 1999;14 (suppl 2):119.

20. Friedmann PD, Zhang JX, Pittinger C, Brooks AR, Saitz R. Does an open-ended introduction or question-order influence the test characteristics of alcohol screening tools? Substance Abuse 2000;21:48-49. Oral presentation.

21. Friedmann PD, Lemon S, Stein MS, D’Aunno TA. Managed care and access to outpatient drug treatment on demand. New England Regional Society of General Internal Medicine Meeting, March 31, 2000, Providence, RI. Oral presentation.

22. Mohiuddin MM (medical student), Tong I, Friedmann PD. MDMA-induced acute hepatitis in a young patient. New England Regional Society of General Internal Medicine Meeting, March 31, 2000, Providence, RI. Medical student oral presentation.

24

23. Friedmann PD, Lemon S, Stein MS, D’Aunno TA. Managed care and access to outpatient drug treatment on demand. American Society of Addiction Medicine 31st Annual Meeting, April 14, 2000, Chicago, IL. J Addict Dis 2000; 19:137. Oral presentation.

24. Tong I (resident), Mohiuddin MM , Friedmann PD. A case of Methylenedioxymeth-amphetamine -induced hepatitis. American College of Physicians / American Society of Internal Medicine Regional Meeting, April 28, 2000, Providence, RI. Resident poster presentation.

25. Mohiuddin MM (medical student), Tong I, Friedmann PD. MDMA-induced acute hepatitis in a young patient. Society of General Internal Medicine 23rd Annual Meeting, May 4, 2000, Boston, MA. J Gen Intern Med 2000; 15(suppl 1):191 . Medical student poster presentation.

26. Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D’Aunno TA. Linkage to medical services

in the Drug Abuse Treatment Outcome Study (DATOS). Society of General Internal Medicine 23rd Annual Meeting, May 5, 2000, Boston, MA. J Gen Intern Med 2000; 15(suppl 1):115. Oral presentation

27. Friedmann PD, Lemon S, Stein MS, D’Aunno TA. Managed care and access to outpatient drug treatment on demand. Society of General Internal Medicine 23rd Annual Meeting, May 5, 2000, Boston, MA. J Gen Intern Med 2000; 15(suppl 1):115. Poster presentation.

28. Friedmann PD, McCullough DM, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Society of General Internal Medicine 23rd Annual Meeting, May 5, 2000, Boston, MA. J Gen Intern Med 2000; 15(suppl 1):115. Poster presentation.

29. Stein, MD, Gogineni, A., Friedmann, PD, Charuvastra, A, Sobota, M, Swift, RM, Longabaugh, R. Alcohol and HIV risk-taking among intravenous drug users. Alcohol Clin Exp Res. 2000; 24(5 suppl):115A.

30. Friedmann PD, Lemon S, Stein MS. Predictors of health status after drug abuse treatment. Substance

Abuse. 2001;22(2):134-135. Oral presentation. 31. Charuvastra A (medical student), Friedmann PD, Stein MD. Physician attitudes toward prescription of

medical marijuana. J Addict Dis. 2001;20(1):11A. Poster Presentation. 32. Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. The effect of primary medical care on

addiction and medical severity in substance abuse treatment programs. Substance Abuse. 2002;23(2):126-127. Oral presentation.

33. Friedmann PD, Ramsey S, Herman D, Charuvastra A, Dube C, Stein MD. Maintenance care for alcohol

problems in remission in primary care. Association for Medical Education and Research in Substance Abuse (AMERSA) 26th National Conference, November 9, 2002. Substance Abuse. 2003;24(1):60-61. Oral presentation.

34. Lemon SC, Friedmann PD, Roy J, Clark MA, Rakowski W. Diffusion of influenza vaccination in the

elderly. Academy for Health Services Research and Health Policy Annual Meeting, Washington DC, June, 2002. Poster presentation.

35. Christensen MH, Boisse N, Sanchez W, Friedmann PD. Enhancing vocational rehabilitation

counselors’ substance abuse screening, assessment and intervention practices. Association for Medical

25

Education and Research in Substance Abuse (AMERSA) 26th National Conference, November 9, 2002. Substance Abuse. 2003;24(1):62. Oral presentation.

36. Friedmann PD, Ramsey SE, Hayaki J, McGraw JD, Stein MD. Maintenance primary care for alcohol-

related disorders in remission. Beyond the Clinic Walls. Expanding Mental Health, Drug and Alcohol Service Research Outside the Specialty Care System. Washington, DC. March 11, 2003. Poster presentation.

37. Friedmann PD, Gerstein DR, Hendrickson JC, Zhang Z. Need-service matching and drug abuse

improvement in the NTIES. Beyond the Clinic Walls. Expanding Mental Health, Drug and Alcohol Service Research Outside the Specialty Care System. Washington, DC. March 12, 2003. Poster presentation.

38. Affleck P, Austin K, Foley T, Love C, Sprague D, Friedmann P, Flanigan T. “Safe Release”: Providing

services for high risk women pre & post release; incarceration & community. Beyond the Clinic Walls. Expanding Mental Health, Drug and Alcohol Service Research Outside the Specialty Care System. Washington, DC. March 12, 2003. Poster presentation.

39. Hayaki J, Friedmann PD, Ramsey S, McGraw JD, Stein MD. Alcohol use disorders in primary care:

correlative validity of DSM-IV early and sustained remission. Association for Medical Education and Research in Substance Abuse (AMERSA) 27th National Conference, November 5, 2003. Substance Abuse. 2004;25(3):74. Poster presentation.

40. Christensen MH, Boisse N, Sanchez W, Friedmann PD. An interdisciplinary networking model of

substance abuse curricular change. Association for Medical Education and Research in Substance Abuse (AMERSA) 27th National Conference, November 6, 2003. Substance Abuse. 2004;25(3):48. Oral presentation.

41. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Does linkage to primary medical

care during addiction treatment reduce subsequent utilization of emergency and hospital care? Drug Abuse. Addiction Health Services Research Conference. Philadelphia, PA. October 8, 2004. Poster presentation.

42. Katz E. Friedmann P. Shaping Behavior Among Drug-Involved Parolees: Step'n Out Study of CJ-

DATS. College of Problems of Drug Dependence. June 22, 2005. Oral presentation. 43. O'Connell, D, Friedmann P. Shaping Behavior Among Drug-Involved Parolees: Step'n Out Study of

CJ-DATS. American Society of Criminology. Toronto, CA, November 2005. Oral presentation. 44. Friedmann PD, Rose JS, Ramsey S, Richards K, Herman D, Paull NE, Swift R, Stout R, Millman RP,

Stein MD. Soporific Intervention to Enhance Sleep and Treatment of Alcoholism (SIESTA). Association for Medical Education and Research in Substance Abuse (AMERSA) 30th National Conference, November 7, 2006. Oral presentation.

45. Taxman FS, Friedmann P, Rhodes A. Step 'n Out: Overview of a Behavioral Management Strategy to

Manage Parolees. Presentation at the American Society of Criminology, Los Angeles, CA, November 2006. Oral presentation.

46. Friedmann PD, Rose JS, Ramsey S, Richards K, Herman D, Paul NE, Swift R, Stout R, Millman RP,

Stein MD. Soporific Intervention to Enhance Sleep and Treatment of Alcoholism (SIESTA).VA HSR&D National Meeting, February 21-23, 2007, Arlington, VA. Oral presentation.

26

47. Friedmann PD “Reentry Strategies for Drug Involved Parolees: The Rhode Island Experience.”

Academic and Health Policy Conference on Correctional Health. Quincy, MA, March 29, 2007. Oral presentation.

48. Katz E, Friedmann PD. Step’n Out: An Approach to Integrating Contingency Management into the

Criminal Justice System. CSAT preconference session: Linking Science and Practice for Substance Use Disorder Treatment & Criminal Justice. 69th

Annual Meeting, College on Problems of Drug

Dependence, Quebec, Canada, June 16, 2007. Oral presentation. 49. Rhodes AG, Friedmann PD. “The Step’n Out Study of CJ-DATS: Preliminary Results Among Drug-

Involved Parolees.” Symposium: Community Reentry of Drug-Involved Offenders. International Academy of Law and Mental Health Conference. University of Padua, Italy, June 26, 2007. Oral presentation.

50. Rhodes AG, Friedmann P, Taxman F et al. Offender Perceptions of Working Relationships with

Officers and Counselors: Impact of a Collaborative Behavioral Model. Addiction Health Services Research Meeting. Athens, GA, October 2007. Oral presentation.

51. Taxman FS, Friedmann P, Rhodes A. Step 'n Out: Preliminary Findings and the Impact of Alliance and

Rapport. Addiction Health Services Research Meeting. Athens, GA, October 2007. Oral presentation. 52. Friedmann PD “The Step’n Out Study of CJ-DATS: Preliminary Results” Academic and Health Policy

Conference on Correctional Health. Quincy, MA, March 28, 2008. Oral presentation. 53. Friedmann P, Taxman FS, Rhodes A. The Step 'n Out Study of Collaborative Behavioral Management

for Drug-Involved Parolees. Addiction Health Services Research Meeting. Boston, MA, October 21, 2008. Oral presentation.

54. Friedmann P, Taxman FS, Rhodes A. The Step 'n Out Study: A Randomized Trial of Collaborative

Behavioral Management for Drug-Involved Parolees. Association for Medical Education and Research in Substance Abuse National Meeting. Washington, DC, November 8, 2008. Oral presentation.

55. Friedmann P, Taxman FS, Rhodes A. Collaborative Behavioral Management Makes Parole More

Supportive. 2nd Annual NIH Conference on the Science of Dissemination and Implementation, NIH Campus, Natcher Conference Center, Bethesda, MD, January 28, 2009. Poster presentation.

56. Johnson JE, Friedmann P, Taxman F. Gender by treatment effects in the Step’N’Out study of

drug-treatment mandated parolees. 33rd Annual National meeting of the Association for Medical Education and Research in Substance Abuse, Bethesda, MD. November 2009. Substance Abuse 2010; 31:212. Poster presentation.

57. Cioe P, Friedmann P, Stein MD. Depressive symptoms among opiate-dependent persons initiating buprenorphine/naloxone. 33rd Annual National meeting of the Association for Medical Education and Research in Substance Abuse, Bethesda, MD. November 2009. Substance Abuse 2010; 31:213. Poster presentation.

58. Hunt J, Garrett S, Cupertino AP, Friedmann PD, Gajewski B, Ellerbeck EF, Richter KP. How

tobacco treatment is currently delivered in drug treatment. 33rd Annual National meeting of the Association for Medical Education and Research in Substance Abuse, Bethesda, MD. November 2009. Substance Abuse 2010; 31:216. Poster presentation.

27

59. Trinh T, Frank J, Samuels A, Poshkus M, Friedmann P. Medical residents behind bars: a unique

clinical experience and linkage project. Rhode Island Chapter, American College of Physicians 2010 Annual Meeting. Med Health Rhode Island. 2010; 92: 333.

60. Frank J (Resident), Samuels A, Reinert S, Trinh T, , Friedmann PD. Emergency department utilization of recently released inmates in Rhode Island- a critical need for linkage to primary care. Society of General Internal Medicine Regional Meeting, April 1, 2010, Providence RI. Oral presentation.

61. Samuels A (Resident), Reinert S, Trinh T, Frank J, Friedmann PD. Health care utilization of the

recently released incarcerated population in rhode island- a critical need for linkage to primary care. Society of General Internal Medicine 33rd Annual Meeting, April 28, 2010, Minneapolis, MN. Poster presentation.

62. Johnson JE, Friedmann P, Taxman F. Gender and treatment response in the Step’n Out study of

substance-use treatment mandated parolees. Annual meeting of the College on Problems of Drug Dependence, January 2010, Scottsdale, AZ. Poster presentation.

63. Johnson JE, Zlotnick C, Friedmann P, Taxman, F. A case for relationships from the edge:

Women prisoners. Annual meeting of the Society for Psychotherapy Research, June 2010, Asilomar, CA. Oral presentation.

64. Tseng VL (medical student), Greenberg PB, Wu WC, Jiang L, Scott IU, Friedmann PD. Cataract

surgery complications in nonagenarians. American Academy of Opthalmology Annual Meeting. Chicago, IL, October 18, 2010. Poster presentation.

65. Friedmann P, Harrington M, Green TC, Rhodes AG, Taxman FS. Collaborative Behavioral

Management reduces drug-related crime, substance use among drug-involved parolees. 34th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), Bethesda, MD, November 6, 2010. Subst Abuse. 2011; 32:58. Oral plenary presentation. Best abstract winner.

66. Li E, Greenberg PB, Tseng V, Caffrey AR, Wu WC, Friedmann PD, LaPlante KL. In vitro

coagulation effects of ophthalmic doses of bevacizumab. 10th Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT), Fort Worth, TX, February 17-20, 2011. Poster presentation.

67. Caffrey AR, Gupta K, Quilliam BJ, Friedmann, PD, LaPlante KL. Quantifying the burden of

Staphylococcus aureus in a regional healthcare system. National Meeting of Infectious Disease Society of America. Boston, MA, October 2011. Oral presentation.

68. Caffrey AR, Gupta K, Quilliam BJ, Friedmann, PD, LaPlante KL. Linezolid utilization in

methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Chicago, Illinois, August 16, 2011. Poster presentation.

69. Faseru B, Hunt JJ, Gajewski B, Jiang Y, Cupertino AP, Marquis J, Friedmann PD, Richter KP.

Development and factorial validation of the tobacco treatment commitment scale (TTCS), 35th Annual National Meeting of the Association for Medical Education and Research

28

in Substance Abuse (AMERSA), Bethesda, MD, November 5, 2011. . Substance Abuse. 2012; 33(2): 214. Poster presentation.

70. Hunt JJ, Cupertino AP, Gajewski B, Jiang Y, Friedmann PD, Marquis J, Richter KP. National

survey of adherence to evidence-based tobacco treatment guidelines in U.S. substance abuse facilities. 35th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), Bethesda, MD, November 5, 2011. . Substance Abuse. 2012; 33(2): 208. Oral presentation.

71. Frank J, Andrews C, Green TC, Samuels A, Trinh TT, Friedmann PD. Emergency department

use for substance use conditions among ex-prisoners. 35th Annual National Meeting of the Association for Medical Education and Research in Substance Abuse (AMERSA), Bethesda, MD, November 5, 2011. Substance Abuse. 2012; 33(2): 210. Oral plenary presentation. Best abstract semi-finalist.

72. Wu WC, Taveira TH, Jeffery S, Tokuda L, Uhrle F, Dooley A, Musial J, Heintz J, Cohen LB,

Lee J, Kawakami C, Gopalakrishnan G, Friedmann P, Jiang L, Sinott P, Eaton CB. Pharmacist-led group medical visits for cardiovascular risk reduction in type 2 diabetes. Late Breaking Session. American Diabetes Association 72nd Annual Scientific Sessions. June 8-12, 2012. Philadelphia, PA.

73. Caffrey AR, Gupta K, Quilliam BJ, Friedmann PD, LaPlante KL. Quantifying Staphylococcus

aureus Disease Burden with Clinical Microbiology Culture Data: Attributable Time Trends in a Regional Healthcare System. To be presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), August 2012; Barcelona, Spain.

74. Caffrey AR, Gupta K, Quilliam BJ, Friedmann PD, LaPlante KL. Antimicrobial Utilization for

Culture-Confirmed Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in a Large, Regional Cohort. To be presented at the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), August 2012; Barcelona, Spain.

75. Green TC, Mann M, Bowman S, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann P.

How does use of a prescription monitoring program change pharmacy practice?" Selected for Oral presentation during the 140th APHA Annual Meeting, October 27 - October 31, 2012, San Francisco, CA.

SCHOLARLY WORK PUBLISHED IN OTHER MEDIA (NON-PEER-REVIEWED) PRIMECare Instructional Video, a 20-minute videotape demonstrating the steps in the PRIMECare Guideline. Providence, RI: Division of General Internal Medicine, Rhode Island Hospital and Lifespan Media Services, 2001. INVITED PRESENTATIONS 1. “Academic Underpinnings of Generalism.” Task Force on Review and Revision of the Medical

School Curriculum, University of Chicago, Chicago, IL. 1995.

29

2. “Improving Emergency Care of Older Persons.” Grand Rounds, Departments of Community Medicine, Emergency Medicine, Geriatrics, and Health Policy, Mount Sinai Medical Center, New York. 1996.

3. “Outcomes Measures: Moving Beyond Mortality Rates.” Clinical Leadership Seminar Series, University of Chicago, Chicago, IL. 1996.

4. “Quest for the Historical Schweitzer.” Chicago Schweitzer Fellows Program, Chicago, IL. 1997.

5. “Making a Difference: Brief Advice for Patients with Alcohol Problems.” Midwest Regional Meeting, Society of General Internal Medicine, Chicago, IL. 1997.

6. “Screening and Brief Advice for Patients with Substance Use Problems.” Primary Care Group

Conference Series, University of Chicago, Chicago, IL. 1997. 7. “Brief Advice for Patients with Substance Use Problems. ” Emergency Department Conference

Series, University of Chicago, Chicago, IL. 1997. 8. “Caring for Patients with Substance Use Disorders: The Role of the Internist.” Department of

Medicine Grand Rounds, University of Chicago, Chicago, IL. February 1998.

9. “Relapse Prevention and Pharmacological Adjuncts.” Substance Abuse Precourse, Society of General Internal Medicine 21st Annual Meeting, Chicago, IL. April 1998.

10. “Making Referrals: Opening the Black Box of Addiction Treatment.” Substance Abuse Precourse, Society of General Internal Medicine 21st Annual Meeting, Chicago, IL. April 1998.

11. “Reframing Substance Abuse: More than Just a Brain Disease.” Boston University Schools of Medicine and Public Health/Join Together Faith & Substance Abuse Leadership Seminar. North Falmouth, MA. September 1998.

12. “Treatment Works: A Primer on Treatment & Recovery.” Boston University Schools of Medicine and Public Health/Join Together Faith & Substance Abuse Leadership Seminar. North Falmouth, MA. September 1998.

13. “Linkages to Medical and Psychosocial Services in Drug Abuse Treatment.” Grand Rounds, Department of Health Policy, Mount Sinai Medical Center, New York. 1998.

14. ”Screening and Brief Interventions for Patients with Alcohol Problems.” Chicago Medical Society 1999 Midwest Clinical Conference, Chicago, IL. January 1999.

15. “Linkage to Medical and Psychosocial Services in Outpatient Drug Abuse Treatment.” Symposium

on Research on Linkage Between Drug Treatment and Other Systems of Care, National Institute on Drug Abuse. Chicago, IL. June 26, 1999.

16. “Linkages to Medical and Psychosocial Services in Drug Abuse Treatment.” Research Conference, Division of General Internal Medicine, Rhode Island Hospital and Brown University, Providence, RI. September 9, 1999.

17. “Syringe Exchange Programs, a Pro Position.” Brotherhood of Temple Emanuel forum on the Worcester needle exchange proposal. Worcester, MA. January 23, 2000.

30

18. “Linkages to Medical Services in the Drug Abuse Treatment Outcomes Study.” Dissertation

Seminar, NIAAA Training Program, The Heller School, Schneider Institute for Health Policy, Brandeis University, Waltham MA. March 13, 2000.

19. “Organizational Correlates of Access to Outpatient Drug Abuse Treatment.” Symposium on

Addiction Treatment Entry, American Public Health Association 128th Annual Meeting & Exposition, Boston, MA. November 13, 2000.

20. “Delirium Tremens.” Panel discussant. Morbidity & Mortality Conference, The Miriam

Hospital, Providence, RI. January 24, 2001. 21. “Promote Recovery in Medical Care: PRIMECare.” Research Conference, Division of General

Internal Medicine, Rhode Island Hospital and Brown University, Providence, RI. May 10, 2001. 22. “Caring for Patients with Substance Use Disorders: The Role of the Internist.” Department of

Medicine Grand Rounds, Memorial Hospital of Rhode Island, Providence, RI. May 30, 2001. 23. “Screening, Assessment, Intervention and Referral.” 3-hour session to faculty fellows of HRSA-

AMERSA-CSAT/SAMHSA Interdisciplinary Program to Improve Health Professional Education in Substance Abuse, Baltimore, MD. May 31, 2001.

24. “Grant writing.” 1.5-hour session to faculty fellows of HRSA-AMERSA-CSAT/SAMHSA

Interdisciplinary Program to Improve Health Professional Education in Substance Abuse (Project MAINSTREAM) Northeast Regional Meeting, Providence, RI. April 26, 2002.

25. “Maintenance Care and Relapse Prevention for Substance-Related Disorders in Remission.” Precourse, Caring for the Substance-Using Patient: Emerging Issues & Ongoing Challenges for the Generalist Physician. Society of General Internal Medicine 25st Annual Meeting, Atlanta, GA. May 2,2002.

26. “Maintenance Care and Relapse Prevention for Substance-Related Disorders in Remission.” Grand Rounds, Boston Healthcare for the Homeless Program, Boston, MA. June 25, 2002.

27. “Grant writing.” 3-hour session to faculty fellows of HRSA-AMERSA-CSAT/SAMHSA Interdisciplinary Program to Improve Health Professional Education in Substance Abuse (Project MAINSTREAM) National Meeting, Washington, DC. November 5, 2002.

28. “Organizational Linkage Between Primary Care and Drug Abuse Services.” Primary Care And Substance Abuse: A Research-Setting Round Table Seminar. National Institute on Drug Abuse. Bethesda, MD. July 18, 2003

29. “Linkages Between Primary Medical Care and Addiction Treatment: Does It Make a

Difference?” Selya Award Address. Lifespan Research Celebration. October 21, 2003.

30. Clarke J, Gibb R, Friedmann PD. “Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Implications for Rhode Island.” 2nd Annual Behavioral Health and Corrections Conference. Community College of Rhode Island, Warwick, RI. October 1, 2003

31

31. “Linkage Between Primary Medical Care and Addiction Treatment: Does It Make a Difference?” Addiction Medicine: Evidence-Based Treatment Strategies. The Division on Addictions at Harvard Medical School. Boston, MA. October 24, 2003.

32. “Office-Based Buprenorphine for Opioid Dependence – Now We Can Do Something.” Medical

Grand Rounds. Saint Anne’s Hospital, Fall River, MA. April 7, 2004. 33. “Linkage Between Primary Medical Care and Addiction Treatment: Does It Make a

Difference?” Providence VAMC Mental Health Grand Rounds. Providence, RI. May 26, 2004. 34. “Organizational Linkage Between Primary Care and Addiction Treatment: Does It Make a

Difference?” Brown University Center for Primary Care & Prevention 2nd Tuesday Research Forum. Memorial Hospital of Rhode Island, Pawtucket, RI. September 14, 2004.

35. Co-Director, ASAM Buprenorphine Training Course. “Efficacy and Safety of Buprenorphine”;

“Special Populations: Adolescents, Pregnancy and Pain”; “Office Procedures and Logistics.” Fall River, MA, May 22, 2004.

36. “Facing the Challenge of Addiction and Hepatitis.” Hepatitis Foundation International Third

Annual National Viral Hepatitis Summit, Baltimore, MD, August 26, 2004. 37. Course Faculty, AOAAM Buprenorphine Training Course. “Special Populations: Adolescents,

Pregnancy and Pain”; “Pharmacology of Buprenorphine”,Providence, RI, January 29, 2005. 38. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Buprenorphine”, “Special Populations: Adolescents, Pregnancy and Pain”; “” Cumberland, MD, March 19, 2005.

39. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Buprenorphine”, “Clinical Management”. Portland, ME, May 21, 2005.

40. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Buprenorphine”, “Office Policies and Clinical Management,” Chicago, IL, June 18, 2005.

41. “Shaping Behavior Among Drug-Involved Parolees: The Step’n Out Study of CJ-DATS.”

International Academy of Law and Mental Health Preconference The Science of Addiction: Policy Implications. Université René Descartes, Paris France, July 3, 2005.

42. “Pain, Addiction or Both? The Community Clinician’s Role.” Practical Strategies for Managing

Pain. Baystate Pain Course. Log Cabin Conference Center, Holyoke, MA, October 19, 2005. 43. “Methamphetamine: A Medical Perspective.” Rhode Island Family Drug Court Annual

Conference. Reviewing Our Past- Preparing For The Future. Radisson Airport Hotel, Warwick, RI. December 7, 2005.

44. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Buprenorphine”, “Office Policies and Clinical Management,” Grand Rapids, MI, March 11, 2006.

32

45. “Reentry Strategies for Drug Involved Parolees: The Rhode Island Experience.” Association of Paroling Authorities International 22nd Annual Conference. Sparks, NV, April 25, 2006.

46. “State Prescription Drug Monitoring Programs.” Chronic Pain Workshop, Part 2: The Dilemma

Between Treating Pain and Endangering Public Health. Society of General Internal Medicine 29th Annual Meeting. Los Angeles, CA. April 29, 2006.

47. Faculty, ASAM Buprenorphine Training Course. “Office Logistics,” “Clinical Management,”

“Medical Comorbidity.” Columbia, MD, June 3, 2006. 48. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Opioids”, “Office Policies and Clinical Management,” “Medical Comorbidity” Augusta, ME, June 17, 2006.

49. Faculty, ASAM Buprenorphine Training Course. “Buprenorphine Induction, Maintenance and

Withdrawal,” “Non-Pharmacological Treatment,” Randolph, MA, November 17, 2006. 50. “Reentry Strategies for Drug Involved Parolees: The Rhode Island Experience.” Academic and

Health Policy Conference on Correctional Health. Quincy, MA, March 29, 2007. 51. “Evidence-based Practices for Drug-Involved Adult Offenders.” Evidence-Based Practices. Federal

Parole and Probation Officers Association National Training Institute. Nashville, TN, April 17, 2007. 52. Faculty, ASAM Buprenorphine Training Course. ““Clinical Management,” “Office Policies and

Logistics,” “Medical Comorbidity.” Hartford, CT, May 5, 2007. 76. “Medical Needs of Drug-Involved Offenders.” Symposium, Drug Abuse Treatment within the

Criminal Justice System: Addressing our Nation's Public Health Needs. American Psychiatric Association Annual Meeting San Diego, CA, May 23, 2007.

77. “The Step’n Out Study of CJ-DATS: Preliminary Results Among Drug-Involved Parolees.”

Symposium: Community Reentry of Drug-Involved Offenders. International Academy of Law and Mental Health Conference. University of Padua, Italy, June 26, 2007.

78. “Nicotine Epidemiology and Medical Comorbidity In Patients with SUDs.” Cape Cod Symposium on

Addictive Disorders, Four Points Sheraton, Hyannis MA. September 8, 2007. 79. “Addiction Medicine: Do We Really Need Doctors with Expertise in Substance Use Disorders?”

NRI/DATA Symposium on Addiction Medicine. Marriott Hotel, Providence RI. November 14, 2007. 80. Course Director, ASAM Buprenorphine Training Course. “Legislation Allowing Office-based

Opioid Dependence Treatment,” “Pharmacology of Opioids”, “Clinical Management,” “Medical Comorbidity” Baltimore, MD, December 8, 2007.

81. “Linkage Between Primary Care, Mental Health and Addiction Treatment.” 5th UK/European

Symposium on Addictive Disorders. Millennium Gloucester Hotel, Kensington, London, England. May 10, 2008.

82. “Should Substance Use Disorders Fall in the Domain of Primary Care.” Preventive Medicine

Associates Annual Meeting. Marriott Hotel, Newton, MA. May 29, 2008.

33

83. “Balancing Legal Implications and Public Health.” Rhode Island Justice Education Summit. Physicians and Lawyers for National Drug Policy. Ray Conference Center, Butler Hospital. September 16, 2008.

84. “Pain, Addiction or Both? The Community Clinician’s Role.” Newport Hospital Grand Rounds,

Newport, RI. December 19, 2008. 85. “Motivational Interviewing 101: The Basics for Primary Care.” Providence VA Medical Center

Primary Care Retreat. February 27, 2009. 86. “Meeting the Medical Needs of Community Correctional Populations.” International

Community Corrections Association 17th Annual Research Conference, Orlando, Florida September 15, 2009.

87. “Pain, Addiction or Both? The Community Clinician’s Role.” Memorial Hospital of Rhode

Island Grand Rounds, Pawtucket, RI. March 3, 2010.

88. “Medically Assisted Treatment Saves Lives, Reduces Crime.” Annual National Meeting. National Association of Drug Court Professionals. Hynes Convention Center, Boston MA. June 2, 2010.

89. “Medically Assisted Treatment: Clearing the Air.” Annual National Meeting. National Association of

Drug Court Professionals. Hynes Convention Center, Boston MA. June 5, 2010.

90. “Update in Addiction Medicine.” Providence VA Medical Center. Medical Service Grand Rounds. August 30, 2010.

91. “Alcohol Withdrawal.” Rhode Island Department of Corrections Health Care Services Grand Rounds.

Cranston RI, December 14, 2010.

92. “Addiction Care for Drug-Involved Offenders Re-entering the Community.” Symposium on Models of Addiction Care. Annual National Medical-Scientific Conference, American Society of Addiction Medicine, Washington Hilton, Washington DC. April 17, 2011.

93. “Adapting Contingency Management/ Community Reinforcement Approaches (CM/CRA) for Drug

Users in Criminal Justice Settings.” NIDA Blending Conference, NIDA/NIH. Bethesda, MD. September 16, 2011

94. “Opioids for Chronic Pain: Minimizing Harm, Optimizing Benefit.” 7th Annual Coastal Medical

CME Seminar. Warwick, RI. September 15, 2011.

95. “Opioids for Chronic Pain: Minimizing Harm, Optimizing Benefit.” Rhode Island Medical Society/NORCAL CME course, Chronic Pain and Opioids: Safe & Effective Management. Warwick, RI. October 12, 2011.

96. “They All Come Home: Health Care for Drug-Involved Inmates Reentering the Community. Division

of General Internal Medicine Grand Rounds. Vanderbilt University, Nashville, TN. February 8,2012.

97. “Opioids for Chronic Pain: Minimizing Harm, Optimizing Benefit.” 35th annual reunion conference for Brown University's Warren Alpert Medical School/Memorial Hospital Family Medicine residency program. Providence, RI. June 8, 2012.

34

98. “Opioids for Chronic Pain: Minimizing Harm, Optimizing Benefit.” Grand Rounds, Women and Infants Hospital of Rhode Island, Providence, RI. June 28, 2012.

GRANTS

“Emergent Care of Chicago’s Older Persons: An Analysis of Prehospital Factors, Quality of Care, and Outcomes.” Chicago Community Trust (12212) and the Retirement Research Foundation (95-122). $277,522. 9/1/1995-8/31/1997. Co-Principal Investigator. “Linkages to Primary Care in Drug Treatment Programs.” National Institute on Drug Abuse Mentored Clinical Scientist Career Development Award (5K08 DA00320). $739,517. 9/1/1996-8/31/2002. Principal Investigator. “Physicians’ Attitudes and Practice Patterns around Substance Abuse.” University of Chicago Home Health Care Research Program. $24,937. 6/1/1997-5/30/1998. Principal Investigator. “Primary Care Relapse Prevention after Addiction Treatment.” Generalist Physician Faculty Scholar Program, The Robert Wood Johnson Foundation. $240,000. 4/1/2000-3/31/04. Principal Investigator. “Linkage to Health Services in Drug Abuse Treatment.” National Institute on Drug Abuse (1R01 DA13615). $600,000. 12/01/2000-08/31/2004. Principal Investigator. “Trazodone for Sleep Disturbance - Early Alcohol Recovery.” National Institute on Alcohol Abuse and Alcoholism (1R01AA13243). $1,288,457. 09/15/2001-08/15/2005. Principal Investigator. “Continuity of Care for Drug-Addicted Offenders in RI.” National Institute on Drug Abuse (3U01 DA016191). 09/25/02-08/31/08. Total costs: $3,193,418. Principal Investigator of the Rhode Island Research Center of NIDA’s multisite National Criminal Justice Drug Abuse Treatment Studies (see http://CJDATS.org). A Brief Alcohol Intervention for Incarcerated Women National Institute on Alcohol Abuse and Alcoholism (1R01 AA014495). 10/01/03-09/30/08. Co-I. “The Drug Abuse Treatment System Survey.” National Institute on Drug Abuse (1R01 DA32727). 05/01/03-4/30/05. Subcontract direct costs $121,208. Co-Investigator. “Program to Integrate Psychosocial & Health Services in Chronic Disease & Disability.” Targeted Research Enhancement Program (TREP). Veterans Affairs Health Services Research & Development (HSR&D TRP 04-179). 09/01/04-08/31/08. Direct costs: $459,000. PI. “An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care Settings: Demonstration Model Site.” Special Projects of National Significance (1H97 HA03801-01-00). Health Resources and Services Administration, 09/01/04-08/31/09. Direct Costs. $230,319. Co-PI. Opiate Replacement Therapy at Release from Incarceration.” National Institute on Drug Abuse (1R01 DA018641). 06/16/05-06/15/10. Co-I.

35

“Antidepressants During Office-based Buprenorphine” National Institute on Drug Abuse (1R01 DA020479). 10/01/05-09/30/10. Co-I. “Insomnia and Drug Relapse Risk.” National Institute on Drug Abuse (1R01 DA020479). 10/01/05-09/30/10. Co-Investigator. “Stabilize Addiction/Affect, Begin Inmates’ Interferon for HCV of Liver (STAABIHL)” National Institute on Drug Abuse (1R01 DA023570) 09/30/07-08/31/10. Direct Costs. $542,971. PI. “Center on Systems, Outcomes & Quality in Chronic Disease & Rehabilitation.” Research Enhancement AWARD Program (TREP). Veterans’ Affairs Health Services Research & Development (HSR&D REA 08-263). 10/01/08-09/30/12. Direct costs: $1,224,000. PI. “Treatment Study Using Depot Naltrexone (2/6) Rhode Island Protocol Treatment Site. ” National Institutes of Health/NIDA (1R01 DA024549). 10/01/2008-09/30/13. Direct costs: $1,226,411. PI Supplement to “Treatment Study Using Depot Naltrexone (2/6) Rhode Island Protocol Treatment Site. ” National Institutes of Health/NIDA (3R01DA024549 - 03S1). 10/01/2011-09/30/13. Direct costs: $77,570. PI “Continuum of Care for Drug-Involved Offenders”. National Institutes of Health/NIDA (3U01 DA016191-06A1). 04/01/09-03/31/14. Total costs: $3,142,965. Principal Investigator of the Rhode Island Research Center of NIDA’s multisite National Criminal Justice Drug Abuse Treatment Studies-2 (see http://CJDATS2.org). “Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics” National Institutes of Health/NIAAA (1R01AA017418-01A1). 04/01/09-03/30/14. Co-I. “Sustaining Tobacco Abstinence after Incarceration” National Institutes of Health/NIDA (1R01 DA024093). 04/01/09-03/30/11. Co-I “Testing a Comprehensive Model of the Diffusion of Evidence-Based Practices” National Institutes of Health/NIDA (1R01 DA030459). 02/01/2011-01/30/2013. Role: Co-I. “Pilot Study of Depot Naltrexone for Alcohol, Dependent, Homeless Veterans” Veterans’ Affairs/HSR&D (1I01 HX000444). 08/01/10-07/30/11. $100,000. PI Supplement to “Treatment Study Using Depot Naltrexone (2/6) Rhode Island Protocol Treatment Site. ” National Institutes of Health/NIDA (3R01DA024549 - 03S1). 10/01/2011-09/30/13. Direct costs: $1,226,411. PI UNIVERSITY TEACHING ROLES

Course Title

Role

Students Per Session

Sessions Per Year

Academic Years

Harvard Medical School, Boston, MA

Preventive Medicine and Nutrition Small group leader

5 7 1992-94

36

Pritzker School of Medicine, University of Chicago, Chicago, IL

Health Outcomes and the Quality of Medical Care

Course Co-Director

~12 11 1995-99

Topics in HIV Lecturer ~40 2 1994-99 Social Context of Medicine Lecturer ~120 1 1997-99 Medicine in Society Lecturer ~12 3 1996-99 Spirituality and Medicine Lecturer ~15 1 1997-99 Advanced Clinical Pharmacology Lecturer ~20 1 1998 PSY310/Perspectives in Drug Abuse Lecturer ~10 1 1998 Medical Student Summer Research Program

Small Group Leader

8 8 1996-98

Brown Medical School, Providence, RI

Post-Doctoral Research Seminar, Center for Alcohol and Addiction Studies

Lecturer ~10 1 2001-

Promote Recovery in Medical Care – a Continuing Education Course

Course Director

6 6 2001

“Research Methods,” Community Health Clerkship

Lecturer ~20 1 2004-06

“Quantitative Methods,” Community Health Clerkship

Small Group Leader

~10 2 2006-

HOSPITAL TEACHING ROLES

Course/Program

Role

Students (S) Residents ® Fellows (F) Per Session

Hours

Per Session

Sessions

Per Year

Academic Years

Montefiore Medical Center, Albert Einstein College of Medicine, NY

Ambulatory Medicine Clinic Preceptor 5 R 4 ~48 1990-91 Emergency Medicine Preceptor 2-4 R, 1 S 12 ~96 1991-92

Deaconess Hospital, Harvard Medical School, Boston, MA

Ambulatory Medicine Clinic Preceptor 2-4 R 4 ~48 1992-94

37

Primary Care Journal Club Facilitator 20 R 1 ~40 1992-94

University of Chicago Hospitals, Pritzker School of Medicine, Chicago, IL

Clinical Appraisal of the Medical Literature

Co-Course Leader

5 R 2 ~48 1994-99

Clinical Skills 2 Small

group leader

5 S 1.5 7 1994-95

Internal Medicine Ward Teaching Attending Physician

1-2 S 3 R 1 F

1.5-3 12 1994-99

Urgent Care Clinic Preceptor 3 R 1 S

4 ~12 1994-99

Maria Shelter Clinic (a student-run homeless shelter clinic)

Preceptor 3 S 3 8 1995-99

Medical Resident Noon Conference

Lecturer 10-20 R 10 S

1 1 1994-99

Emergency Medicine Resident Noon Conference

Lecturer 10 R 5 S

1 1 1996-99

Primary Care Noon Conference Lecturer 5-10 R

3-5 S 1 1 1994-99

Rhode Island Hospital, Brown Medical School, Providence RI

Physical Diagnosis Preceptor 2 S 1.5 ~12 1999-01 Clerkship in Medicine Preceptor 5 S 1.5 ~5 2000 Internal Medicine Ward Teaching

Attending Physician

1 S 3 R 1 F

1.5-3 12 1999-05

Medical Primary Care Unit Preceptor 3-5 R 3 S

4 ~48 1999-05

Medical Resident Noon Conference (RI Hospital)

Lecturer 10-20 R 10S

1 2 1999-06

Medical Resident Noon Conference (Memorial Hospital of RI)

Lecturer 10-20 R 10S

1 1 1999-03

Primary Care Resident Ambulatory Morning Report

Preceptor 5 R 1 3 2000-06

Primary Care Resident Behavioral Medicine Conference

Lecturer 5 R 2 3 2000-05

38

Ambulatory Block – Critical Appraisal Curriculum

Lecturer 5 R 2.5 3 2002-06

Ambulatory Block – Substance Abuse Curriculum

Lecturer 5 R 2 5 2002-

Primary Care Resident Professionalism Conference

Lecturer 5 R 1 2 2007-

Miriam Hospital, Brown Medical School, Providence RI

Fain General Internal Medicine Clinic

Preceptor 3-5 R 4 ~48 2001-05

Providence Veterans Affairs Medical Center, Brown Medical School, Providence RI

Internal Medicine Ward Teaching

Attending 2 R 1.5-3 12 2005-06

Primary Care Clinic Preceptor 1 S 3 46 2007-08 TEACHING & RESEARCH SETTINGS

TRAINEE TYPE PERIOD DEGREE INSTITUTION STIPEND CURRENT

POSITION Elliott, L. Jr Fac 1998-01 MD U. Chicago Hartford Asst Prof Med

U.Chicago Ballard- Lubelczyk, R.

Post 1999-01 MD Brown/RIH HRSA/GIM Fellow

Attending Physician, Walpole MA

Diaz, J. Post 1999-01 MD Brown/RIH HRSA/GIM Fellow

Asst. Prof Med, Brown

Lemon, S. Pre 1999-01 PhD Brown/RIH Doctoral Candidate

Asst Prof. Med, U. Mass.

Hayaki, J. Post 2002-04 PhD Brown/RIH Psychology T32 Instructor Psychology, Macalester U.

Charuvastra, A. Pre 2000-02 MD Brown/RIH Medical Student Child Psych Fellow, NYU

Arnedt, J.T. Post 2002-04 PhD Brown/RIH NIAAA K08 Asst Prof Med U. Michigan

Sanchez, W. Post 2000-04 PhD Northeastern U. HRSA/AMERSA/CSAT SAMHSA

Assoc Prof Consult Psych Northeastern

Boisse, N. Post 2000-04 PhD Northeastern U. HRSA/AMERSA/CSAT SAMHSA

Assoc Prof Pharmacology, Northeastern

Christensen, M. Post 2000-04 RN, PhD Northeastern U. HRSA/AMERSA/CSAT SAMHSA

Prof Nursing, Northeastern

Russell, P. Post 2000-04 MD Brown/RIH Medical Resident Heme/Onc

39

Fellow McGraw, J. Pre 2000-04 MS Brown/RIH Doctoral

Candidate -

Resnik, L. Jr. Fac 2004-08 PhD Brown/Providence VAMC

VA HSR&D Assoc Prof Comm Health, Brown

Wu, W. Jr. Fac 2004-08 MD Brown/Providence VAMC

VA HSR&D Assoc Prof Med, Brown

Pirraglia, P. Jr. Fac 2004-09 MD Brown/Providence VAMC

VA HSR&D CDA

Asst Prof Med, Brown

Taylor, L. Post 2004-09 MD Brown/RIH NIDA K23 Asst Prof Med, Brown

Hatgis, C. Post 2005-7 PhD Brown/RIH Psychology T32 Asst. Prof Psych Boston U.

Beckwith, C Jr Fac. 2006-11 MD Brown/TMH NIDA K23 Assoc Prof Med, Brown

Johnson, J. Jr Fac 2006-11 PhD Brown/W&I NIDA K23 Assoc Prof Psych & Hum Behav (Res), Brown

Trivedi, A. Jr Fac 2007- MD Brown/Providence VAMC

VA HSR&D CDA-2, RWJ Fac Scholar

Asst Prof HSP&P, Brown

Dosa, D Jr Fac 2008- MD Brown/Providence VAMC

VA HSR&D CDA-2

Asst Prof Med, Brown

Trinh, T. Post 2009-11 MD Brown/RIH Medical Resident Gen Med Fellow, Harvard

Samuels, A. Post 2009-10 MD Brown/RIH Medical Resident EIS, CDC, Atlanta GA

Zaller, N Jr Fac 2009- PhD Brown/TMH Jr. Faculty Asst Prof Med (Res) Brown

Green, TC Jr Fac 2009- PhD Brown/RIH CDC grant, R21 Asst Prof Med (Res) Brown

Greenberg, PB Jr Fac 2009- MD Brown/VAMC Jr. Faculty. Asst Prof Surg Brown

Murphy, J Jr Fac 2009- RN, PhD Univ of RI/VAMC Jr. Faculty Asst Prof Nursing, URI

Caffrey, A Jr Fac 2010- PhD Univ of RI/VAMC VISN1 Career Dev Award

Asst Prof Pharm, URI

Andrews, C Pre-doc 2010- MA U. Chicago Dissertation grant

Doctoral student

Rounsaville, D Post-doc 2011- PhD Brown/RIH T32 T32 fellow